Bristol-Myers Squibb
BMY
BMY
2,276 hedge funds and large institutions have $76.3B invested in Bristol-Myers Squibb in 2025 Q2 according to their latest regulatory filings, with 150 funds opening new positions, 812 increasing their positions, 1,028 reducing their positions, and 309 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
22% less capital invested
Capital invested by funds: $97.3B → $76.3B (-$21B)
51% less first-time investments, than exits
New positions opened: 150 | Existing positions closed: 309
56% less funds holding in top 10
Funds holding in top 10: 36 → 16 (-20)
Holders
2,276
Holding in Top 10
16
Calls
$1.12B
Puts
$1.26B
Top Buyers
| 1 | +$503M | |
| 2 | +$472M | |
| 3 | +$451M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$425M |
| 5 |
BC
Broadwater Capital
Boston,
Massachusetts
|
+$403M |
Top Sellers
| 1 | -$522M | |
| 2 | -$417M | |
| 3 | -$361M | |
| 4 |
Bank of New York Mellon
New York
|
-$278M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$250M |
